Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 289

1.
2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
3.

Effect of comorbid anxiety on treatment response in bipolar depression.

Tohen M, Calabrese J, Vieta E, Bowden C, Gonzalez-Pinto A, Lin D, Xu W, Corya S.

J Affect Disord. 2007 Dec;104(1-3):137-46. Epub 2007 May 21.

PMID:
17512607
4.

Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.

Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S.

J Affect Disord. 2008 Jan;105(1-3):101-8. Epub 2007 May 24.

PMID:
17531327
5.

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.

Yatham LN, Kennedy SH, O'Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P, Beaulieu S, Daigneault A, Milev R, Young LT, Ravindran A, Schaffer A, Connolly M, Gorman CP; Canadian Network for Mood and Anxiety Treatments.

Bipolar Disord. 2005;7 Suppl 3:5-69. Review.

PMID:
15952957
6.

Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.

van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

J Clin Psychiatry. 2009 Feb;70(2):223-31. Epub 2008 Dec 30.

PMID:
19200421
7.

Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study.

Pan PY, Lee MS, Lo MC, Yang EL, Yeh CB.

BMC Psychiatry. 2014 May 19;14:145. doi: 10.1186/1471-244X-14-145.

8.

The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial.

Ketter TA, Greist JH, Graham JA, Roberts JN, Thompson TR, Nanry KP.

J Clin Psychiatry. 2006 Mar;67(3):400-6.

PMID:
16649826
9.

A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R.

J Clin Psychiatry. 2004 Mar;65(3):432-41.

PMID:
15096085
10.

Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex.

Houston JP, Ahl J, Meyers AL, Kaiser CJ, Tohen M, Baldessarini RJ.

J Clin Psychiatry. 2006 Aug;67(8):1246-52.

PMID:
16965203
11.

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.

Yatham LN, Kennedy SH, O'Donovan C, Parikh SV, MacQueen G, McIntyre RS, Sharma V, Beaulieu S; Guidelines Group, CANMAT.

Bipolar Disord. 2006 Dec;8(6):721-39.

PMID:
17156158
12.

Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.

Gao K, Muzina D, Gajwani P, Calabrese JR.

J Clin Psychiatry. 2006 Sep;67(9):1327-40. Review.

PMID:
17017818
13.

Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.

Hirschfeld RM, Weisler RH, Raines SR, Macfadden W; BOLDER Study Group.

J Clin Psychiatry. 2006 Mar;67(3):355-62.

PMID:
16649820
14.

Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.

Sanger TM, Grundy SL, Gibson PJ, Namjoshi MA, Greaney MG, Tohen MF.

J Clin Psychiatry. 2001 Apr;62(4):273-81.

PMID:
11379842
15.

A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.

Brown EB, McElroy SL, Keck PE Jr, Deldar A, Adams DH, Tohen M, Williamson DJ.

J Clin Psychiatry. 2006 Jul;67(7):1025-33.

PMID:
16889444
16.
17.

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J; Lamictal 605 Study Group.

J Clin Psychiatry. 2003 Sep;64(9):1013-24.

PMID:
14628976
18.

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.

Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL.

Am J Psychiatry. 2005 Jul;162(7):1281-90.

PMID:
15994710
19.

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

Tohen M, Chengappa KN, Suppes T, Zarate CA Jr, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2002 Jan;59(1):62-9.

PMID:
11779284
20.

Long-term lamotrigine plus lithium for bipolar disorder: One year outcome.

Ghaemi SN, Schrauwen E, Klugman J, Berv DA, Shirzadi AA, Pardo TB, Goodwin FK.

J Psychiatr Pract. 2006 Sep;12(5):300-5.

PMID:
16998417

Supplemental Content

Support Center